Non-invasive diagnostics through breath biomarkers with Breath Biopsy technology.
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Grant Owlstone Medical received a grant of up to $49.1 million from ARPA-H for at-home breath-based multi-cancer screening. | $49.1M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.